Fibroblast growth factors in cancer: therapeutic possibilities.
about
Gentisic acid, a compound associated with plant defense and a metabolite of aspirin, heads a new class of in vivo fibroblast growth factor inhibitorsTargeting FGFR4 inhibits hepatocellular carcinoma in preclinical mouse modelsDendrimer-based tumor cell targeting of fibroblast growth factor-1AHNAK2 is a potential prognostic biomarker in patients with PDAC.Fibroblast growth factor receptor-mediated signals contribute to the malignant phenotype of non-small cell lung cancer cells: therapeutic implications and synergism with epidermal growth factor receptor inhibition.FGFR4 profile as a prognostic marker in squamous cell carcinoma of the mouth and oropharynx.Tissue-specific regulation of pregnane X receptor in cancer development and therapy.Tyrosine kinases as targets in cancer therapy - successes and failures.Fibroblast growth factor receptor mediates fibroblast-dependent growth in EMMPRIN-depleted head and neck cancer tumor cells.The broad-spectrum anti-DNA virus agent cidofovir inhibits lung metastasis of virus-independent, FGF2-driven tumors.Targeting the heparin-binding domain of fibroblast growth factor receptor 1 as a potential cancer therapy.Fibroblast growth factor receptors as therapeutic targets in human melanoma: synergism with BRAF inhibition.Inhibition of fibroblasts reduced head and neck cancer growth by targeting fibroblast growth factor receptor.Regulation of growth factor signaling by FRS2 family docking/scaffold adaptor proteins.Cooperative dimerization of fibroblast growth factor 1 (FGF1) upon a single heparin saccharide may drive the formation of 2:2:1 FGF1.FGFR2c.heparin ternary complexes.Fibroblast growth factor family as a potential target in the treatment of hepatocellular carcinoma.Fibroblast growth factor receptor 4 as a potential prognostic and therapeutic marker in colorectal cancer.PD173074, a selective FGFR inhibitor, reverses ABCB1-mediated drug resistance in cancer cells.Tumour cell responses to new fibroblast growth factor receptor tyrosine kinase inhibitors and identification of a gatekeeper mutation in FGFR3 as a mechanism of acquired resistance.Reactivation of mitogen-activated protein kinase (MAPK) pathway by FGF receptor 3 (FGFR3)/Ras mediates resistance to vemurafenib in human B-RAF V600E mutant melanoma.Control of fibroblast growth factor (FGF) 7- and FGF1-induced mitogenesis and downstream signaling by distinct heparin octasaccharide motifs.Targeting FGF19 inhibits tumor growth in colon cancer xenograft and FGF19 transgenic hepatocellular carcinoma models.FGFR4 as a Biomarker in Squamous Cell Cancers of Mouth and Oropharynx
P2860
Q24298832-FF90334D-3B07-4F2E-80A3-ECD3AFE8E39FQ28729944-18093F62-3A99-4D4B-B8D9-49A6BA2B47FFQ33638152-9B9E638E-FC7F-4A67-8436-28C8A90FD20CQ33761904-82B724DB-A111-4470-8A13-157F7824933EQ33890597-0FCB3CC4-2F2C-4CD2-9054-54ECB2B0D1A6Q34505851-789CEC83-0D29-48B8-8788-2777F00BF764Q34545411-3B89FCF6-FF33-45AD-BD54-354DE68833DCQ35095147-95ACB8B2-03DA-4F60-B564-2629702E0780Q35169068-6DA52DCD-03E7-4C95-B999-0B20666C2D29Q35741522-E434218D-5047-432B-86F6-76CDB06B87FEQ35881055-C207CB01-A65D-4905-BA78-08FF7722EC1AQ36059811-B8927115-F09C-4E41-82F4-E183FAAADDD8Q36249025-97F4C191-040D-4FB4-B687-51A95C1BAF33Q37152909-5403DC38-D234-4451-AC41-9FACAD5337E8Q38320039-A94DFD82-6AA4-4B71-B381-B46A5BFF8DBBQ38923517-37EFF276-1A69-4675-A0AF-8B047ABB264CQ39035706-697E01DD-2D1E-4C9F-8283-33434BF8921CQ39152151-0AA8747A-F64A-4EC4-9CC9-CBF8DB665D84Q39301436-B7F1B7B1-4CA5-47A6-B58C-08B5672723CBQ39325740-6FA616E3-3C34-4CBB-A496-6BCD0D0A6BAFQ42801360-E100C3AB-32DC-4228-9B82-6AB7A79E2370Q53331692-B81F3488-1691-4860-B693-ED93F23D508DQ57556242-1B7FA8D2-8869-4CCA-85E7-CD8DC630920A
P2860
Fibroblast growth factors in cancer: therapeutic possibilities.
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Fibroblast growth factors in cancer: therapeutic possibilities.
@ast
Fibroblast growth factors in cancer: therapeutic possibilities.
@en
Fibroblast growth factors in cancer: therapeutic possibilities.
@nl
type
label
Fibroblast growth factors in cancer: therapeutic possibilities.
@ast
Fibroblast growth factors in cancer: therapeutic possibilities.
@en
Fibroblast growth factors in cancer: therapeutic possibilities.
@nl
prefLabel
Fibroblast growth factors in cancer: therapeutic possibilities.
@ast
Fibroblast growth factors in cancer: therapeutic possibilities.
@en
Fibroblast growth factors in cancer: therapeutic possibilities.
@nl
P2093
P2860
P356
P1476
Fibroblast growth factors in cancer: therapeutic possibilities.
@en
P2093
Henri S Lichenstein
Michael Jeffers
William J LaRochelle
P2860
P304
P356
10.1517/14728222.6.4.469
P407
P577
2002-08-01T00:00:00Z